1,516 articles
William E. Boden
William E. Boden is an American cardiologist, Professor of Medicine at Boston University and Harvard lecturer, known for leading trials of stenting versus medical therapy in coronary disease.
William E. Kraus
William E. Kraus is an American preventive cardiologist at Duke University School of Medicine, a distinguished professor since 2017, best known for the STRRIDE trials of how exercise amount and intensity affect cardiometabolic risk.
William F. Fearon
William F. Fearon is an American interventional cardiologist who is Chief of Interventional Cardiology at Stanford and led the FAME trials of FFR-guided stenting.
William G. Stevenson
William G. Stevenson is an American cardiac electrophysiologist, Professor of Medicine at Vanderbilt University Medical Center since 2017, known for catheter ablation and cardiac mapping for ventricular tachycardia.
William Grossman
William Grossman is an American cardiologist known for research on the heart's diastolic function and as editor of the standard catheterization textbook Grossman's Cardiac Catheterization, Angiography and Intervention.
William H. Daughaday
William H. Daughaday (1918–2013) was an American endocrinologist at Washington University in St. Louis who founded modern growth hormone research and formulated the somatomedin hypothesis.
William H. Dietz
William H. Dietz is an American physician-scientist and professor at George Washington University, known as the father of childhood obesity research and a CDC division director from 1997 to 2012.
William H. Frishman
William H. Frishman, born 1946, is an American cardiologist and pharmacology researcher, Chair Emeritus of Medicine at New York Medical College, known for NEJM beta-blocker reviews and Cardiovascular Pharmacotherapeutics.
William H. Gaasch
William H. Gaasch (1937–2022) was an American cardiologist at Tufts Medical Center and the Lahey Clinic whose work on diastolic function shaped how clinicians diagnose heart failure.
William H. Herman
William H. Herman is an American physician-scientist at the University of Michigan who led economic analyses of the Diabetes Prevention Program and chaired the National Clinical Care Commission.
William J. McKenna
William J. McKenna, also published as W J McKenna, is a Canadian-born British cardiologist and Emeritus Professor at UCL known for identifying genes behind inherited cardiomyopathies and sudden-death risk.
William Jeffcoate
William Jeffcoate is a retired British endocrinologist in Nottingham known for his work on the diabetic foot, including the 2003 Lancet review Diabetic foot ulcers.
William Jefferson Darby
William Jefferson Darby (1913–2001) was an American physician, biochemist, and nutrition scientist at Vanderbilt University who researched folic acid, dietary sodium and blood pressure, and food-additive policy.
William L. Haskell
William L. Haskell (born 1937) is an American exercise physiologist and preventive-cardiology researcher, emeritus professor at Stanford, who chaired the 2008 Physical Activity Guidelines Advisory Committee.
William N. Valentine
William N. Valentine was an American hematologist and physician-scientist who, as chairman of medicine at UCLA, established inherited red-cell enzyme deficiencies as a major cause of hereditary hemolytic anemia.
William P. Castelli
William P. Castelli (1931–2025) was an American cardiovascular epidemiologist who directed the Framingham Heart Study from 1979 to 1995 and established HDL cholesterol as protective against coronary heart disease.
William R. Hiatt
William R. Hiatt (1950–2020) was an American cardiologist at the University of Colorado who led the EUCLID and VOYAGER PAD trials in peripheral artery disease.
William S. Weintraub
William S. Weintraub (William Weintraub) is an American cardiologist and outcomes researcher known for leading trials of medical therapy versus revascularization, including the COURAGE trial.
William S. Yancy
William S. Yancy Jr. is an American physician-investigator and Professor of Medicine at Duke University who studies dietary treatments for obesity and type 2 diabetes, including low-carbohydrate ketogenic diets.
William T. Abraham
William T. Abraham is an American cardiologist and physician-scientist at The Ohio State University who led landmark heart failure trials, including the MIRACLE trial of cardiac resynchronization therapy.
William T. Cefalu
William T. Cefalu is an American physician-scientist in diabetes and endocrinology, director of NIDDK's diabetes division since 2019 and formerly chief scientific, medical, and mission officer of the American Diabetes Association.
William V. Tamborlane
William V. Tamborlane was an American pediatric endocrinologist at Yale School of Medicine who pioneered insulin pump therapy and led the Yale center in the Diabetes Control and Complications Trial.
William W. O’Neill
William W. O’Neill is an American interventional cardiologist who performed the first TAVR in the United States, pioneered angioplasty for heart attacks, and led the PAMI trial.
William W. Parmley
William W. Parmley was an American cardiologist who spent 30 years at UCSF, including 25 as cardiology chief, and was known for research on heart failure and secondhand smoke.
William Wijns
William Wijns is a Belgian interventional cardiologist who was Co-Director of the Cardiovascular Center Aalst from 1994 to 2016 and is now a professor at the University of Galway.
Wojciech Zaręba
Wojciech Zaręba is a cardiologist at the University of Rochester and inaugural David Mortara Endowed Professor in Cardiology, known for noninvasive electrocardiology and the MADIT-CRT and MADIT-RIT trials.
Woldemar Mobitz
Woldemar Mobitz (1889–1951) was a German internist and cardiologist, born in St. Petersburg, who in 1924 classified second-degree AV block into the two types that still carry his name.
Wolfgang Kasper
Wolfgang Kasper is a German internist and cardiologist, medical director at St. Josefs-Hospital Wiesbaden from 1993 to 2016, known for the PE-3 thrombolysis trial in pulmonary embolism.
Wolfgang Köenig
Wolfgang Koenig is a German cardiologist and professor at the Technical University of Munich whose 1999 study showed C-reactive protein predicts coronary heart disease risk in initially healthy middle-aged men.
Wylie Vale
Wylie W. Vale, Jr. (1941–2012) was an American neuroendocrinologist at the Salk Institute who determined the structures of corticotropin-releasing factor and growth hormone-releasing hormone, and co-founded Neurocrine Biosciences.